Oxford AstraZeneca Covishield: Will reserve enough coronavirus vaccine doses for Parsis, says Adar Poonawalla

Image Source : FILE Covishield: Will reserve enough coronavirus vaccine doses for Parsis, says Adar Poonawalla “More than enough” doses of the COVID-19 vaccine developed by Oxford University and AstraZeneca will be reserved for the Parsi community, Adar Poonawalla, chief executive officer of the vaccine’s local manufacturer Serum Institute of…

Read More Oxford AstraZeneca Covishield: Will reserve enough coronavirus vaccine doses for Parsis, says Adar Poonawalla

India has fantastic ‘vaccine capability’; will be crucial in COVID-19 fight: UK envoy

NEW DELHI: India has a fantastic “vaccine capability” and it would play a crucial role in the partnerships the UK is building on COVID-19 vaccine development and manufacturing, the new British High Commissioner said on Thursday. British High Commissioner Philip Barton also said India is “really important” to the UK…

Read More India has fantastic ‘vaccine capability’; will be crucial in COVID-19 fight: UK envoy
AstraZeneca-Oxford University coronavirus COVID-19 vaccine shows promising results after first human trial

AstraZeneca-Oxford University coronavirus COVID-19 vaccine shows promising results after first human trial | World News

London: AstraZeneca`s experimental COVID-19 vaccine was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday, with the strongest response seen in people who received two doses.  The vaccine, called AZD1222 and being developed by AstraZeneca and scientists at the Britain`s University of…

Read More AstraZeneca-Oxford University coronavirus COVID-19 vaccine shows promising results after first human trial | World News